Litigation Details for Forest Laboratories, LLC v. Hikma Pharmaceuticals LLC (D. Del. 2014)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2014-10-02
Court	District Court, D. Delaware	Date Terminated	2017-07-11
Cause	35:271 Patent Infringement	Assigned To	Sue Lewis Robinson
Jury Demand	None	Referred To	Sherry R. Fallon
Parties	WEST-WARD PHARMACEUTICALS CORP.
Patents	7,741,358; 8,022,228
Attorneys	Jack B. Blumenfeld
Firms	Shaw Keller LLP
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2014-10-02	1		. 14. United States Patent No. 7,741,358 (“the ’358 patent”), titled “Crystal Form of Asenapine…United States Patent No. 7,741,358 constitutes infringement of one or more claims of said patent under 35 … a) declare that United States Patent Nos. 7,741,358 and 8,022,228 are valid; …)(2)(A), Hikma infringed United States Patent Nos. 7,741,358 and 8,022,228 by submitting ANDA No. 206117…than the expiration date of United States Patent Nos. 7,741,358 and 8,022,228, including any exclusivities	External link to document
2017-07-11	27		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,358 B2; 8,022,228 B2; 5,763,476…2014 11 July 2017 1:14-cv-01266 830 Patent None District Court, D. Delaware	External link to document
2014-10-02	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,358 B2; 8,022,228 B2;. …2014 11 July 2017 1:14-cv-01266 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document